Pfizer Near Potential $7.3 Billion Metsera Takeover, FT Says

Pfizer Inc. is closing in on a potential $7.3 billion takeover of obesity startup Metsera Inc., the Financial Times reported, as the drug giant looks to bolster its pipeline after the recent failure of its closely-watched weight-loss pill.

The deal could be announced as early as Monday, the FT reported, citing unidentified people familiar with the matter.